Targeting Annexin A2 to reactivate tumor-associated antigens presentation and relieve immune tolerance in liver cancer

Targeting Annexin A2 to reactivate tumor-associated antigens presentation and relieve immune tolerance in liver cancer

Background Tumor cells manipulate the tumor-associated antigens presentation to escape immune surveillance; however, the molecular mechanism is not exactly clear and the measure to intervene is missing.Methods Annexin A2 was knockout by the CRISPR-Cas9 or blocked by the small-molecule matrine, PY60,...

Full description

Saved in:
Bibliographic Details
Main Authors: Min Li, Hui Shen, Feng Xie, Feng Lu, Jianxin Yang, Yuxiao Tang, Qicong Shen, Zelong Gao, Mengpu Wu, Chenghua Wu, Jicong Du, Changquan Ling, Yifeng Chai, Xin Dong, Jianxin Qian, Chenqi Li, Zhenhong Guo, Dongyao Wang
Format: Article
Language:English
Published: BMJ Publishing Group 2025-06-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/13/6/e011716.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://jitc.bmj.com/content/13/6/e011716.full

Similar Items